Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Avenue Capital Group has teamed up with China Medical...
BioBay, the Suzhou life science park, formed a cancer...
Xizang Haisco Pharma, a Tibetan TCM company, staged a...
Mindray Medical paid $35.5 million for a controlling...
WuXi PharmaTech is forming a JV with PRA, a US-based...
BioPacific Investors, an US group of angel investors, has...
Dr. Arthur Taveras, a US pharma executive with 24 years...
ChemPartner, the preclinical CRO/CMO division of China's...
WuXi PharmaTech, through its WuXi NextCODE Genomics...
ChemPartner, the CRO component of China-US...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
